Study of Apatinib Combined With TACE in Advance Hepatocellular Carcinoma

NCT03398122 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

248

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

PROCEDURE: TACE
DRUG: Apatinib

Sponsor

Tianjin Medical University Cancer Institute and Hospital